Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Key Market Feature
1.4 Market Outline
1.5 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Process Phase
6.1 Hit generation and selection
6.2 Target ID/Validation
6.3 Lead Optimisation
6.4 Lead Identification
Chapter 7 Market Segmentation by Therapeutic Areas
7.1 Cardiovascular
7.2 Oncology
7.3 Metabolic
7.4 Respiratory
7.5 Orthopedics
7.6 Gastrointestinal
7.7 Dermatology
7.8 Immunological
7.9 Anti-Infective
7.10 Others
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.4 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company profiles
10.1 Abbvie Inc
10.1.1 Business Overview
10.1.2 Product Portfolio
10.1.3 Key Strategy
10.1.4 Recent Developments
10.2 Bayer Ag
10.3 Albany Molecular Research Inc
10.4 Biocon Ltd
10.5 Allergan Plc
10.6 Boehringer Ingelheim Gmbh
10.7 Amgen Inc
10.8 Bristol-Myers Squibb Company
10.9 Aptuit
10.10 Charles River Laboratories International Inc
10.11 Astellas Pharma Inc
10.12 Eli Lilly and Company
10.13 Evotec Ag
10.14 F Hoffmann-La Roche Ag
10.15 Astellas Pharma Inc
Chapter 11 Market Estimates and Forecasts
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Process Phase 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Therapeutic Area 2018-2024 (USD Million)
11.1.3 Market Estimation and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
